StockCall Early Morning Insight into St. Jude Medical, Hologic, Navidea Biopharma, ResMed, and Edwards Lifesciences
LONDON, April 16, 2013 /PRNewswire/ --
While President Obama's Affordable Care Act (ACA) has been seen by many as being beneficial to the healthcare industry, the reform has been fiercely opposed by the medical appliances & equipment industry. This is because medical appliances & equipment companies have been levied with a 2.3% tax on total U.S. gross sales of medical devices and equipment under the ACA. Companies such as St. Jude Medical Inc. (NYSE: STJ), Hologic Inc. (NASDAQ: HOLX), Navidea Biopharmaceuticals Inc. (AMEX: NAVB), ResMed Inc. (NYSE: RMD), and Edward Lifesciences Corp. (NYSE: EW) say that the ACA will lead to higher costs for the industry, and hurt innovation as companies will be forced to scale back their research and development activities. Shares of medical appliances & equipment companies ended mostly lower in Monday's trading session, tracking losses in the broad market. StockCall has issued technical analysis and charting reports on STJ, HOLX, NAVB, RMD, and EW. Download these free reports now at
http://www.stockcall.com/todaysopinions
Shares of St. Jude Medical Inc. saw a sharp decline in Monday's trading session. The stock closed 2.87% lower at $41.26 on above average volume of 2.57 million. Despite the significant drop, St. Jude Medical's shares are still trading close to their 52-week high of $43.76. The stock has gained nearly 14.90% so far in 2013, outperforming the S&P 500. However, the stock has slipped below its 50-day moving average yesterday, which is a bearish signal. Download the free research on STJ today by registering at
http://www.StockCall.com/STJ041613.pdf
Shares of Hologic Inc. struggled in yesterday's trading session, extending their losses from last week. The stock ended the day 1.83% lower at $21.50 on volume of 1.80 million, taking its losses in the last three sessions to nearly 2.50%. Hologic's shares currently have support at around $21.50. The stock has slipped below its 50-day moving average as a result of recent losses, which is a bearish signal. The downbeat trend is further confirmed by the stock's MACD chart. Sign up and have access to our free report on HOLX at
http://www.StockCall.com/HOLX041613.pdf
Shares of Navidea Biopharmaceuticals Inc. were among the major losers in the healthcare sector on Monday. The stock closed 3.88% lower at $2.48 on volume of 1.37 million, taking its losses in the last three trading sessions to over 6%. Navidea's shares touched an intra-day low of $2.47. The stock is now trading close to its 52-week low of $2.14. Year-to-date, shares of NAVB have fallen nearly 12.40%, underperforming the broad market. Sign up and read the complimentary report on NAVB at
http://www.StockCall.com/NAVB041613.pdf
Share of ResMed Inc. also came under pressure on Monday. The stock fell 3.70% to finish the day at $44.04, which was also its intra-day low. Volume was up from daily average of 1.06 million to 1.19 million. Despite the sharp decline on Monday, ResMed's shares are still up more than 6.30% thus far this year. The stock, however, has slipped below its 50-day moving average, which indicates that market sentiment has turned bearish. The free report on RMD can be downloaded by signing up now at
http://www.StockCall.com/RMD041613.pdf
Edward Lifesciences Corp.'s shares fell to an intra-day low of $83.50 before paring some of the losses to finish the day 1.34% lower at $83.66 on volume of 950,347. Year-to-date, the stock has fallen more than 7.20%, underperforming the S&P 500. Shares of EW are now trading nearly 24.50% below their 52-week high. Free report on EW can be accessed by registering at
http://www.StockCall.com/EW041613.pdf
About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at
SOURCE StockCall.com
Share this article